EMEA-002211-PIP01-17

  • Email
  • Help

Overview

Product details for -
Invented name-
Active substance

Resminostat

Decision numberP/0376/2017
PIP numberEMEA-002211-PIP01-17
Pharmaceutical form(s)Coated tablet
Condition(s)/indication(s)

Treatment of cutaneous T-cell lymphoma

Route(s) of administrationOral use
PIP applicant

4SC AG
Tel. +49 897007630
E-mail: public@4sc.com

Decision typeW: decision granting a waiver in all age groups for all conditions/indications

Decision